XFAB.PA#127
Thesis
Sub-$2B MC silicon photonics foundry validated by NVDA/NOK, CHIPS act grants subsidizing capex, leading in SiPh foundry
Original post text
Tbh $XFAB lowkey reminds me of early $TSEM. Just sub <$2B MC. You basically never find a company with $NVDA and $NOK actively validating your pre-commercial silicon photonics foundry… (photonixFAB) While getting CHIPS act/Gov grants to subsidize capex. While leading the
🐂 Bull Case
- NVDA/NOK validated SiPh foundry + CHIPS act grants → subsidized capex with tier-1 customer pipeline
- Sub-$2B MC with unique pure-play SiPh foundry positioning; compounding as photonics scales
- Price at 52w high (97¢ of range) with Weinstein Stage 2 breakout confirmed
🐻 Bear Case
- Tiny profit margin (2.2%) and negative revenue growth (-4.2%); revenue traction unproven
- D/E 41x with current ratio below 1 (0.91); liquidity risk if capex increases
- Gross margin only 19.8% → limited operating leverage at scale
🚫 Invalidation
Close below $7 (SMA50) on above-average volume, indicating breakout failure
Break Conditions
- Price fails to hold above $10 (prior resistance) on pullback
- CHIPS act grants delayed or denied
Price Tracking
| Label | Ticker | Price | Recorded |
|---|---|---|---|
| t+3d | XFAB.PA | $10.26 | 2026-06-05 18:35:35 |
Metadata
T0 Price: $11.63
Created: 2026-06-02 18:33:59
Scored: 2026-06-02T18:36:46.654289+00:00
Updated: 2026-06-05T18:35:35.604733+00:00